Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M006187200 on November 20, 2000

J. Biol. Chem., Vol. 276, Issue 7, 4709-4716, February 16, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/7/4709    most recent
M006187200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, B.
Right arrow Articles by Ma, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, B.
Right arrow Articles by Ma, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of delta -Opioid Receptor at Serine 344, Resulting in beta -Arrestin- and Clathrin-mediated Receptor Internalization*

Bin XiangDagger , Guo-Hua Yu§, Jun GuoDagger , Li ChenDagger , Wei HuDagger , Gang Pei§, and Lan MaDagger

From the Dagger  National Laboratory of Medical Neurobiology, Fudan University Medical Center, Shanghai 200032, and § Shanghai Institute of Biochemistry and Cell Biology, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People's Republic of China

The purpose of the current study is to investigate the effect of opioid-independent, heterologous activation of protein kinase C (PKC) on the responsiveness of opioid receptor and the underlying molecular mechanisms. Our result showed that removing the C terminus of delta  opioid receptor (DOR) containing six Ser/Thr residues abolished both DPDPE- and phorbol 12-myristate 13-acetate (PMA)-induced DOR phosphorylation. The phosphorylation levels of DOR mutants T352A, T353A, and T358A/T361A/S363S were comparable to that of the wild-type DOR, whereas S344G substitution blocked PMA-induced receptor phosphorylation, indicating that PKC-mediated phosphorylation occurs at Ser-344. PKC-mediated Ser-344 phosphorylation was also induced by activation of Gq-coupled alpha 1A-adrenergic receptor or increase in intracellular Ca2+ concentration. Activation of PKC by PMA, alpha 1A-adrenergic receptor agonist, and ionomycin resulted in DOR internalization that required phosphorylation of Ser-344. Expression of dominant negative beta -arrestin and hypertonic sucrose treatment blocked PMA-induced DOR internalization, suggesting that PKC mediates DOR internalization via a beta -arrestin- and clathrin-dependent mechanism. Further study demonstrated that agonist-dependent G protein-coupled receptor kinase (GRK) phosphorylation sites in DOR are not targets of PKC. Agonist-dependent, GRK-mediated receptor phosphorylation and agonist-independent, PKC-mediated DOR phosphorylation were additive, but agonist-induced receptor phosphorylation could inhibit PKC-catalyzed heterologous DOR phosphorylation and subsequent internalization. These data demonstrate that the responsiveness of opioid receptor is regulated by both PKC and GRK through agonist-dependent and agonist-independent mechanisms and PKC-mediated receptor phosphorylation is an important molecular mechanism of heterologous regulation of opioid receptor functions.


* This work was supported by grants from the National Natural Science Foundation of China (39825110 and 39625015) and the Ministry of Science and Technology (G1999054003 and G1999053907) and by the Ministry of Education and the Shanghai Municipal Commission of Science and Technology.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: National Laboratory of Medical Neurobiology, Fudan University Medical Center, 138 Yi Xue Yuan Rd., Shanghai 200032, P. R. China. Tel.: 86-21-6404-1900 (ext. 2522); Fax: 86-21-6471-8563; E-mail: lanma@shmu.edu.cn.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. M. Urs, A. P. Kowalczyk, and H. Radhakrishna
Different Mechanisms Regulate Lysophosphatidic Acid (LPA)-dependent Versus Phorbol Ester-dependent Internalization of the LPA1 Receptor
J. Biol. Chem., February 29, 2008; 283(9): 5249 - 5257.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Markovic, N. Papadopoulou, T. Teli, H. Randeva, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos
Differential Responses of Corticotropin-Releasing Hormone Receptor Type 1 Variants to Protein Kinase C Phosphorylation
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1032 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function
Mol. Pharmacol., September 1, 2006; 70(3): 1132 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Breit, K. Gagnidze, L. A. Devi, M. Lagace, and M. Bouvier
Simultaneous Activation of the {delta} Opioid Receptor ({delta}OR)/Sensory Neuron-Specific Receptor-4 (SNSR-4) Hetero-Oligomer by the Mixed Bivalent Agonist Bovine Adrenal Medulla Peptide 22 Activates SNSR-4 but Inhibits {delta}OR Signaling
Mol. Pharmacol., August 1, 2006; 70(2): 686 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. L. Bartoe, W. L. McKenna, T. K. Quan, B. K. Stafford, J. A. Moore, J. Xia, K. Takamiya, R. L. Huganir, and L. Hinck
Protein interacting with C-kinase 1/protein kinase Calpha-mediated endocytosis converts netrin-1-mediated repulsion to attraction.
J. Neurosci., March 22, 2006; 26(12): 3192 - 3205.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. M. Patwardhan, K. A. Berg, A. N. Akopain, N. A. Jeske, N. Gamper, W. P. Clarke, and K. M. Hargreaves
Bradykinin-Induced Functional Competence and Trafficking of the {delta}-Opioid Receptor in Trigeminal Nociceptors
J. Neurosci., September 28, 2005; 25(39): 8825 - 8832.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. D. Little, M. E. Hemler, and C. S. Stipp
Dynamic Regulation of a GPCR-Tetraspanin-G Protein Complex on Intact Cells: Central Role of CD81 in Facilitating GPR56-G{alpha}q/11 Association
Mol. Biol. Cell, May 1, 2004; 15(5): 2375 - 2387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Li, B. Xiang, W. Su, X. Zhang, Y. Huang, and L. Ma
Agonist-induced Formation of Opioid Receptor-G Protein-coupled Receptor Kinase (GRK)-G{beta}{gamma} Complex on Membrane Is Required for GRK2 Function in Vivo
J. Biol. Chem., August 8, 2003; 278(32): 30219 - 30226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Perron, Z.-g. Chen, D. Gingras, D. J. Dupre, J. Stankova, and M. Rola-Pleszczynski
Agonist-independent Desensitization and Internalization of the Human Platelet-activating Factor Receptor by Coumermycin-Gyrase B-induced Dimerization
J. Biol. Chem., July 18, 2003; 278(30): 27956 - 27965.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Rochdi and J.-L. Parent
Galpha q-coupled Receptor Internalization Specifically Induced by Galpha q Signaling. REGULATION BY EBP50
J. Biol. Chem., May 9, 2003; 278(20): 17827 - 17837.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Chauvin, M. Bencsik, T. Bambino, and R. A. Nissenson
Parathyroid Hormone Receptor Recycling: Role of Receptor Dephosphorylation and {beta}-Arrestin
Mol. Endocrinol., December 1, 2002; 16(12): 2720 - 2732.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kalandadze, Y. Wu, and M. B. Robinson
Protein Kinase C Activation Decreases Cell Surface Expression of the GLT-1 Subtype of Glutamate Transporter. REQUIREMENT OF A CARBOXYL-TERMINAL DOMAIN AND PARTIAL DEPENDENCE ON SERINE 486
J. Biol. Chem., November 22, 2002; 277(48): 45741 - 45750.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Srinivasan, H. Fujino, and J. W. Regan
Differential Internalization of the Prostaglandin F2alpha Receptor Isoforms: Role of Protein Kinase C and Clathrin
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 219 - 224.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, A.-L. Matharu, G. Pula, D. Holman, P. J. Roberts, and E. Kelly
Metabotropic Glutamate Receptor 1 Internalization Induced by Muscarinic Acetylcholine Receptor Activation: Differential Dependency of Internalization of Splice Variants on Nonvisual Arrestins
Mol. Pharmacol., May 1, 2002; 61(5): 1114 - 1123.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X Wu, N Kushwaha, P R Albert, and N J Penington
A critical protein kinase C phosphorylation site on the 5-HT1A receptor controlling coupling to N-type calcium channels
J. Physiol., January 1, 2002; 538(1): 41 - 51.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. McLaughlin and C. Chavkin
Tyrosine Phosphorylation of the {micro}-Opioid Receptor Regulates Agonist Intrinsic Efficacy
Mol. Pharmacol., June 1, 2001; 59(6): 1360 - 1368.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
X. Wu, N. Kushwaha, P.R. Albert, and N.J. Penington
A critical protein kinase C phosphorylation site on the 5-HT1A receptor controlling coupling to N-type calcium channels
J. Physiol., December 3, 2001; (2001) 200101266.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement